Clinical Guidelines for Management of XXXX Associated with Sj  gren Disease.

@entity1 @entity32 @entity2194 @entity3749 @entity936
PURPOSE: To provide a consensus clinical guideline for management of @entity2194 associated with Sj  gren disease by evaluating published treatments and recommending management options. DESIGN: Consensus panel evaluation of reported treatments for @entity2194 . METHODS: Using the 2007 Report of the International Workshop on @entity936 (DEWS) as a starting point, a panel of eye care providers and consultants evaluated peer-reviewed publications and developed recommendations for evaluation and management of @entity2194 associated with Sj  gren disease. Publications were graded according to the American Academy of Ophthalmology Preferred Practice Pattern guidelines for level of evidence. Strength of recommendation was according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. RESULTS: The recommendations of the panel are briefly summarized herein. Evaluation should include symptoms of both discomfort and visual disturbance as well as determination of the relative contribution of @entity3749 and evaporative loss of tear volume. Objective parameters of tear film stability, tear osmolarity, degree of lid margin disease, and ocular surface damage should be used to stage severity of @entity2194 to assist in selecting appropriate treatment options. @entity1 education with regard to the nature of the problem, aggravating factors, and goals of treatment is critical to successful management. Tear supplementation and stabilization, control of @entity32 of the lacrimal glands and ocular surface, and possible stimulation of tear production are treatment options that are used according to the character and severity of @entity2194 . SUMMARY: Management guidelines for @entity936 associated with Sj  gren's disease are presented.
